FOXM1 is expressed in many cancers and has been demonstrated to be directly regulated by the canonical Wnt/β-catenin signaling pathway, contributing to the development of the cancer phenotype, including proliferation, decreased apoptosis, metastasis, and drug resistance [41]. The gene discussed is FOXM1; the disease is cancer.